EcoDrugPlus

Integrin Subunit Beta 6

Ensembl ID : ENSPLAG00000013879
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSPLAG00000019954
Gene Symbol: ITGB8
2 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSPLAG00000023276
Gene Symbol: IRAK4
3 Cross references
200 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4-Like

Ensembl ID : ENSPLAG00000010023
Gene Symbol: LOC106965283
4 Cross references
199 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSPLAG00000022653
Gene Symbol: LOC106958654
3 Cross references
183 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSPLAG00000014639
Gene Symbol: LOC106942683
3 Cross references
203 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSPLAG00000008872
Gene Symbol: LOC106941079
3 Cross references
203 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSPLAG00000023100
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSPLAG00000001302
Gene Symbol: IDH2
3 Cross references
186 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSPLAG00000020843
Gene Symbol: LOC106953397
3 Cross references
207 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSPLAG00000018426
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSPLAG00000017865
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).